These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 28848709)

  • 1. New Treatment Opportunities in Phosphatase and Tensin Homolog (PTEN)-Deficient Tumors: Focus on PTEN/Focal Adhesion Kinase Pathway.
    Alfieri R; Giovannetti E; Bonelli M; Cavazzoni A
    Front Oncol; 2017; 7():170. PubMed ID: 28848709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Focal adhesion kinase phosphorylates the phosphatase and tensin homolog deleted on chromosome 10 under the control of p110δ phosphoinositide-3 kinase.
    Tzenaki N; Aivaliotis M; Papakonstanti EA
    FASEB J; 2015 Dec; 29(12):4840-52. PubMed ID: 26251180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Expression and Prognostic Impact of the PI3K/AKT/mTOR Signaling Pathway in Advanced Esophageal Squamous Cell Carcinoma.
    Wu N; Du Z; Zhu Y; Song Y; Pang L; Chen Z
    Technol Cancer Res Treat; 2018 Jan; 17():1533033818758772. PubMed ID: 29463194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor suppressor PTEN inhibition of cell invasion, migration, and growth: differential involvement of focal adhesion kinase and p130Cas.
    Tamura M; Gu J; Takino T; Yamada KM
    Cancer Res; 1999 Jan; 59(2):442-9. PubMed ID: 9927060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphorylation of phosphatase and tensin homolog induced by
    Yang Z; Cao X; Xu W; Xie C; Chen J; Zhu Y; Lu N
    Oncol Lett; 2018 Jan; 15(1):1051-1057. PubMed ID: 29399165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New insights into Notch1 regulation of the PI3K-AKT-mTOR1 signaling axis: targeted therapy of γ-secretase inhibitor resistant T-cell acute lymphoblastic leukemia.
    Hales EC; Taub JW; Matherly LH
    Cell Signal; 2014 Jan; 26(1):149-61. PubMed ID: 24140475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PTEN inhibits the invasion and metastasis of gastric cancer via downregulation of FAK expression.
    Zhang LL; Liu J; Lei S; Zhang J; Zhou W; Yu HG
    Cell Signal; 2014 May; 26(5):1011-20. PubMed ID: 24486402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced efficacy of AKT and FAK kinase combined inhibition in squamous cell lung carcinomas with stable reduction in PTEN.
    Cavazzoni A; La Monica S; Alfieri R; Ravelli A; Van Der Steen N; Sciarrillo R; Madeddu D; Lagrasta CAM; Quaini F; Bonelli M; Fumarola C; Cretella D; Digiacomo G; Tiseo M; Peters GJ; Ardizzoni A; Petronini PG; Giovannetti E
    Oncotarget; 2017 Aug; 8(32):53068-53083. PubMed ID: 28881794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PTEN improve renal fibrosis in vitro and in vivo through inhibiting FAK/AKT signaling pathway.
    Du Y; Liu P; Chen Z; He Y; Zhang B; Dai G; Xia W; Liu Y; Chen X
    J Cell Biochem; 2019 Oct; 120(10):17887-17897. PubMed ID: 31144376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frequent PTEN loss and differential HER2/PI3K signaling pathway alterations in salivary duct carcinoma: Implications for targeted therapy.
    Saintigny P; Mitani Y; Pytynia KB; Ferrarotto R; Roberts DB; Weber RS; Kies MS; Maity SN; Lin SH; El-Naggar AK
    Cancer; 2018 Sep; 124(18):3693-3705. PubMed ID: 30289966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression levels of phosphatase and tensin homolog deleted on chromosome 10 (PTEN) and focal adhesion kinase in patients with multiple myeloma and their relationship to clinical stage and extramedullary infiltration.
    Wang SY; Hao HL; Deng K; Li Y; Cheng ZY; Lv C; Liu ZM; Yang J; Pan L
    Leuk Lymphoma; 2012 Jun; 53(6):1162-8. PubMed ID: 22149168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Jianpijiedu fang improves survival of hepatocarcinoma mice by affecting phosphatase and tensin homolog, phosphoinositide 3-kinase, and focal adhesion kinase.
    Sun B; Meng J; Xiang T; Chen Z; Li Y; Lu L; Zhang S; Chen X
    J Tradit Chin Med; 2013 Aug; 33(4):479-85. PubMed ID: 24187869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro and in vivo anti-malignant melanoma activity of Alocasia cucullata via modulation of the phosphatase and tensin homolog/phosphoinositide 3-kinase/AKT pathway.
    Fang M; Zhu D; Luo C; Li C; Zhu C; Ou J; Li H; Zhou Y; Huo C; Liu W; Peng J; Peng Q; Mo Z
    J Ethnopharmacol; 2018 Mar; 213():359-365. PubMed ID: 29180042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High Efficacy of Combination Therapy Using PI3K/AKT Inhibitors with Androgen Deprivation in Prostate Cancer Preclinical Models.
    Marques RB; Aghai A; de Ridder CMA; Stuurman D; Hoeben S; Boer A; Ellston RP; Barry ST; Davies BR; Trapman J; van Weerden WM
    Eur Urol; 2015 Jun; 67(6):1177-1185. PubMed ID: 25220373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of PI3K-AKT-mTOR pathway sensitizes endometrial cancer cell lines to PARP inhibitors.
    Philip CA; Laskov I; Beauchamp MC; Marques M; Amin O; Bitharas J; Kessous R; Kogan L; Baloch T; Gotlieb WH; Yasmeen A
    BMC Cancer; 2017 Sep; 17(1):638. PubMed ID: 28886696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of PTEN/AKT/FAK pathways by PPARγ impacts on fibrosis in diabetic nephropathy.
    Yan R; Wang Y; Shi M; Xiao Y; Liu L; Liu L; Guo B
    J Cell Biochem; 2019 May; 120(5):6998-7014. PubMed ID: 30652342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ROCK1 promotes migration and invasion of non‑small‑cell lung cancer cells through the PTEN/PI3K/FAK pathway.
    Hu C; Zhou H; Liu Y; Huang J; Liu W; Zhang Q; Tang Q; Sheng F; Li G; Zhang R
    Int J Oncol; 2019 Oct; 55(4):833-844. PubMed ID: 31485605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical expression of mTOR negatively correlates with PTEN expression in gastric carcinoma.
    Li M; Sun H; Song L; Gao X; Chang W; Qin X
    Oncol Lett; 2012 Dec; 4(6):1213-1218. PubMed ID: 23205120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phosphatase and tensin homolog (PTEN) mutation can cause activated phosphatidylinositol 3-kinase δ syndrome-like immunodeficiency.
    Tsujita Y; Mitsui-Sekinaka K; Imai K; Yeh TW; Mitsuiki N; Asano T; Ohnishi H; Kato Z; Sekinaka Y; Zaha K; Kato T; Okano T; Takashima T; Kobayashi K; Kimura M; Kunitsu T; Maruo Y; Kanegane H; Takagi M; Yoshida K; Okuno Y; Muramatsu H; Shiraishi Y; Chiba K; Tanaka H; Miyano S; Kojima S; Ogawa S; Ohara O; Okada S; Kobayashi M; Morio T; Nonoyama S
    J Allergy Clin Immunol; 2016 Dec; 138(6):1672-1680.e10. PubMed ID: 27426521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PI3K isoform-selective inhibition in neuron-specific PTEN-deficient mice rescues molecular defects and reduces epilepsy-associated phenotypes.
    White AR; Tiwari D; MacLeod MC; Danzer SC; Gross C
    Neurobiol Dis; 2020 Oct; 144():105026. PubMed ID: 32712265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.